Abstract |
A case of early-onset sclerolimbal ectasia following low-dose topical mitomycin C application during uveitic glaucoma surgery is reported. Intraoperative and postoperative clinical courses were consistent with sclerolimbal ectasia. Adjunctive utilization of intraoperative low-dose 0.02% mitomycin C for the management of chronic uveitic glaucoma patients who are under concomitant systemic immunosuppressive regimen may enhance the risk of subacute postoperative sclerolimbal ectasia. Mitomycin C concentrations < 0.02%, decreased scleral exposure time, and a strict informed consent policy are strongly recommended in this subset of uveitic patients.
|
Authors | A Pirouzian, H O'Halloran, C Scher, Y Jockin |
Journal | Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
(Ophthalmologica)
Vol. 220
Issue 6
Pg. 406-8
( 2006)
ISSN: 0030-3755 [Print] Switzerland |
PMID | 17095889
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright 2006 S. Karger AG, Basel. |
Chemical References |
- Alkylating Agents
- Mitomycin
|
Topics |
- Adolescent
- Alkylating Agents
(administration & dosage, adverse effects)
- Combined Modality Therapy
- Corneal Diseases
(chemically induced)
- Dilatation, Pathologic
(chemically induced)
- Glaucoma, Open-Angle
(drug therapy, surgery, therapy)
- Humans
- Intraocular Pressure
- Male
- Mitomycin
(administration & dosage, adverse effects)
- Scleral Diseases
(chemically induced)
- Trabeculectomy
- Uveitis, Anterior
(drug therapy, surgery, therapy)
|